A paradigm shift has happened with drastic cost reduction and improvements in the workflow and accuracy of Nextgen sequencing. In general, Nextgen is replacing several classical clinical tests by improved accuracy, enhanced safety for patient, and lower cost of test. In this talk, recent progress in Nextgen sequencing will be discussed. Furthermore, several examples will be provided on how Nextgen is being implemented to study circulating biomarkers in biological fluids.